Alzheimer’s Drug Discovery Foundation (ADDF): LOI

(Proposal due 10.12, LOI 2 weeks prior)

* ApoE Therapeutics Innovation Program-novel therapeutics specifically designed to target apoE pathological mechanisms. Funding: Pre-clinical-$300K for up to 2 years; Clinical-up to $1 million.

*Preclinical Drug Discovery and Biomarker Development – Funding: ~$150K for 1 year

*ADDF/NIH - assistance for relevant NIH grant applications that were scored but not funded.

http://www.alzdiscovery.org/research-and-grants/request-for-proposal